Europe (WHO region) vs Lao People's Democratic Republic: New cases tested for RR-/MDR-TB
Europe (WHO region)
88.0%
in 2024
Lao People's Democratic Republic
100.0%
in 2024
Europe (WHO region) rank
3rd
Lao People's Democratic Republic rank
1st
New cases tested for RR-/MDR-TB over time
- Europe (WHO region)
- Lao People's Democratic Republic
How they compare
Lao People's Democratic Republic currently reports 100.0% against 88.0% in Europe (WHO region), a difference of 12.0%.
That makes Lao People's Democratic Republic's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 1 time across 13 shared years of data; in 2012 it was Europe (WHO region) ahead.
Europe (WHO region) ranks 3rd and Lao People's Democratic Republic ranks 1st of 11 groups.
Across the 2 decades both report, Europe (WHO region) averaged higher in 1 and Lao People's Democratic Republic in 1.
Head to head by decade
| Decade | Europe (WHO region) | Lao People's Democratic Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 89.1% | 44.2% | 45.0% | Europe (WHO region) |
| 2020s | 90.8% | 97.8% | 7.0% | Lao People's Democratic Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Europe (WHO region) or Lao People's Democratic Republic?
- Lao People's Democratic Republic, at 100.0% against 88.0% in Europe (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Europe (WHO region) and Lao People's Democratic Republic?
- 12.0%, with Lao People's Democratic Republic ahead.
- How many years of comparable data are there for Europe (WHO region) and Lao People's Democratic Republic?
- 13 years are reported by both, from 2012 to 2024.
- How do Europe (WHO region) and Lao People's Democratic Republic rank globally for new cases tested for rr-/mdr-tb?
- Europe (WHO region) ranks 3rd and Lao People's Democratic Republic ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.